Please login to the form below

Not currently logged in
Email:
Password:

Sanofi biologics supply VP joins Kite Pharma

Dr Jian Irish becomes senior vice president of supply chain

California-based Kite Pharma has appointed Dr Jian Irish as senior vice president of supply chain.

Dr Irish joins the immunotherapy-focused firm from Sanofi, where she most recently served as vice president of biologics strategic supply. Prior to this, Dr Irish was vice president of biologics product development technology transfer at the French pharma company.

She also brings pharmaceutical supply chain management experience from Amgen, where she served as executive director and general manager of Japan Asia Pacific supply chain, as well as executive director and global head of contract manufacturing.

Tim Moore, executive vice president of technical operations at Kite Pharma, said: “Jian brings a wealth of supply chain and product development experience to Kite, as well as extensive international business acumen.

"Her willingness to embrace new opportunities to innovate, coupled with her ability to partner and cultivate talent, makes Jian a great addition to the Technical Operations senior leadership team.”

4th January 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics